Institute of Biomedical Research Corp. (MRES)
OTCMKTS · Delayed Price · Currency is USD
0.0066
+0.0004 (5.97%)
Oct 1, 2025, 3:51 PM EDT
MRES Market Cap
MRES has a market cap or net worth of $14.87 million as of October 1, 2025. Its market cap has decreased by -11.43% in one year.
Market Cap
14.87M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 31, 2016, MRES's market cap has increased from 693.95K to 14.87M, an increase of 2,043.37%. That is a compound annual growth rate of 38.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 14.87M | -69.00% |
| Dec 31, 2024 | 47.98M | 138.03% |
| Dec 29, 2023 | 20.16M | 17.54% |
| Dec 30, 2022 | 17.15M | 149.69% |
| Dec 31, 2021 | 6.87M | 971.43% |
| Dec 31, 2020 | 641.05K | 75.00% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 726.52M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 649.73M |
| Northwest Biotherapeutics | 382.67M |
| CytoDyn | 324.34M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 279.44M |